Is CVE-2026-41085 actively exploited?

No active exploitation of CVE-2026-41085 has been confirmed so far. Continue monitoring, as exploit status can change.

Can CVE-2026-41085 be exploited remotely?

Yes. CVE-2026-41085 is exploitable remotely over the network (CVSS attack vector: Network).

What is the CVSS score of CVE-2026-41085?

CVE-2026-41085 has a CVSS score of 8.8 (HIGH).

HOME VULNERABILITIESCVE-2026-41085

HIGH

CVE-2026-41085

CWE-269Published: May 18, 2026· Updated: May 18, 2026

8.8

CVSS v3.1

EPSS:0.04%probability of exploitation in 30 daysPercentile:11.7th

Official Description

Thermo Fisher Scientific Torrent Suite Dx through 5.14.2 has a privilege escalation vulnerability that may allow an authenticated user with limited access privileges to gain unauthorized administrator-level privileges through exploitation of specific system interfaces.

NVD Source

Technical Analysis

CVE-2026-41085 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 8.8.